Expanded Access to Venetoclax

Conditions

• Chronic Lymphocytic Leukemia (CLL)
• Multiple Myeloma
• Acute Myeloid Leukemia (AML)
• Non-Hodgkin's Lymphoma
• Acute Lymphoblastic Leukemia (ALL)
• Amyloidosis
• Plasma Cell Leukemia

Interventions

• DRUG: Venetoclax

Sponsor

AbbVie